Evidence map›Paper›PMID 30355574›Full record

ArticleAnnals of the rheumatic diseases2019

Antony Nicodemus Antoniou, Izabela Lenart, Janos Kriston-Vizi, Takao Iwawaki, Mark Turmaine, Kirsty McHugh, Sadfer Ali, Neil Blake, Paul Bowness, Mona Bajaj-Elliott and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Annals of the rheumatic diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Emerging Strategies against Non-TyphoidalCurrent issues in molecular biology · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Infection and immunity · 2022
    Article
  14. Article
  15. Article
  16. Journal of immunology research · 2022
    Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 3 countries.

Antony Nicodemus AntoniouThe Advanced Centre for Biochemical Engineering, University College London, London, UK antony.antoniou@northumbria.ac.uk.
Izabela LenartSciencePharma, Warszawa, Poland.
Janos Kriston-ViziLaboratory for Molecular Cell Biology, Medical Research Council, University College London, London, UK.
Takao IwawakiDivision of Cell Medicine, Department of Life Science, Medical Research Institute, Kanazawa Medical University, Uchinada, Japan.
Mark TurmaineDivision of Biosciences, University College London, London, UK.
Kirsty McHughNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, UK.
Sadfer AliThe Advanced Centre for Biochemical Engineering, University College London, London, UK.
Neil BlakeInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Paul BownessNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, UK.
Mona Bajaj-ElliottGreat Ormond Street, Institute of Child Health, University College London, London, UK.
Keith GouldWright-Fleming Institute, Imperial College London, London, UK.
Darren NesbethThe Advanced Centre for Biochemical Engineering, University College London, London, UK.
Simon J PowisSchool of Medicine and Biological Sciences Research Complex, University of St Andrews, London, UK.
Biochemical Society · GBUniversity of Oxford · GBGreat Ormond Street Hospital · GBImperial College London · GBKanazawa Medical University · JPMedical Research Council · GBNorthumbria University · GBSciencePharma (Poland) · PLUniversity College London · GBUniversity of Liverpool · GBUniversity of St Andrews · GB

Funding

Arthritis Research UK 17868Arthritis Research UK 18440Arthritis Research UK 21261Medical Research Council MC_EX_G0800785
6 · The paper itself

Abstract

objective

methodsIsogenic epithelial cell lines expressing two copies of either HLA-B*27:05 and a control HLA-B*35:01 heavy chain (HC) were generated to determine the effect on the

results

conclusionsHLA-B27 misfolding and a UPR cellular environment are associated with enhanced

Indexed as

Activating Transcription Factor 6Arthritis, ReactiveCell CycleCell LineEpithelial CellsHLA-B27 AntigenHLA-B35 AntigenHumansProhibitinsSalmonella entericaSalmonella InfectionsUnfolded Protein ResponseX-Box Binding Protein 1Activating Transcription Factor 6ATF6 protein, humanHLA-B27 AntigenHLA-B35 AntigenPHB2 protein, humanProhibitinsX-Box Binding Protein 1ankylosing spondylitisinfectionslipidsreactive arthritisspondyloarthritis

Identifiers

PMID30355574
PMCPMC6317449
OpenAlexW2898231027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.